The new report “Belgium and Netherlands Advanced Wound Care Market”, By Type, Wound Type, End Users, Distribution Channel, Geography – Industry Trends and Forecast to 2024
- Advertising -
The “Belgium and Netherlands Advanced…nd Care Market”, By Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), By Distribution Channel (Direct Tenders Public, Retail Private), By Geography (Europe – Belgium, Netherlands)– Industry Trends and Forecast to 2024
Belgium Advanced Wound Care Market is expected to reach USD 28.0 million by 2024 from USD 22.6 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Netherlands advanced wound care market is expected to reach USD 167.9 million by 2024 from USD 135.4 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
- Advertising -
The major factors driving the growth of this market include rising aging and geriatric population, technological advancement, government support, rising incidences of chronic wound, increase in number of surgeries and increasing trend. On the other hand, low awareness, slow growth rate and shrinking market, complex regulatory approval process, competition with other moist dressings that may hinder the growth of the market.
TABLE OF CONTENTS
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. MARKET SCOPE
1.4. OVERVIEW OF BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET
1.5. CURRENCY AND PRICING
1.7. MARKETS COVERED
- MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICI
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
- MARKET OVERVIEW
3.1.1. RISING AGING AND GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENT
3.1.3. GOVERNMENT SUPPORT
3.1.4. RISING INCIDENCES OF CHRONIC WOUND
3.1.5. INCREASE IN NUMBER OF SURGERIES
3.1.6. INCREASING TREND
3.2.1. LOW AWARENESS
3.2.2. SLOW GROWTH RATE AND SHRINKING MARKET
3.2.3. COMPLEX REGULATORY APPROVAL PROCESS
3.2.4. COMPETITION WITH OTHER MOIST DRESSINGS
3.3.2. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.3.3. UNMET NEEDS
3.3.4. INCREASING DEMAND
3.4.1. SHORTAGE OF TRAINED STAFF
3.4.2. THE DEVELOPMENT OF SUBSTITUTE PRODUCTS
3.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
3.5.1. SMART DRESSING WILL PUSH FUTURE GROWTH
3.5.2. HYDROFIBER HAS BEEN THE MOST SIGNIFICANT RECENT INNOVATION
3.5.3. ALGINATE DRESSING IS EXPECTED TO GROW ROBUSTLY IN THE UPCOMING YEARS
3.5.4. FOAM DRESSING ACCOUNTING THE LARGEST MARKET SEGMENT IN THE UPCOMING YEARS
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET, BY TYPE
6.4. THERAPY DEVICES
- BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET, BY WOUND TYPE
7.2. SURGICAL WOUND
7.2.1. CLASS I
7.2.2. CLASS II
7.2.3. CLASS III
7.2.4. CLASS IV
7.3. DIABETIC ULCERS
7.4. PRESSURE ULCERS
7.5. VENOUS ULCERS
- BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET, BY END USER
- BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
- BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET, BY REGION
10.1. BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET
10.1.1. BELGIUM ADVANCED WOUND CARE MARKET
10.1.2. NETHERLANDS ADVANCED WOUND CARE MARKET
- BELGIUM AND NETHERLANDS ADVANCED WOUND CARE MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: BELGIUM
11.2. COMPANY SHARE ANALYSIS: NETHERLANDS
- COMPANY PROFILES
12.1. ACELITY L.P. INC.
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. SMITH AND NEPHEW
12.2.1. COMPANY OVERVIE
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. MOLNLYCKE HEALTH CARE AB
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. CONVATEC INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. ETHICON INC
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.8.5. PRODUCT PORTFOLIO
12.8.6. RECENT DEVELOPMENTS
12.9. PAUL HARTMANN LIMITED
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
- RELATED REPORTS
The Belgium and Netherlands advance wound care market is segmented on the basis of type, wound type, end-user, distribution channel, and geography. The Belgium and Netherlands advance wound care market is segmented into three types, such as dressing, therapy devices and biologics.
In 2017, the Belgium and Netherlands dressing segment is expected to dominate the market with a share of 62.1% and 61.2% respectively and is expected to continue this trend till 2024.
Dressing is further segmented into foam dressings, hydrogels, film dressings, alginates, wound contact layer, and super absorbent dressing. biologics market is further segmented into synthetic skin grafts, growth factors, allografts, and xenografts.
The therapy devices are further segmented into negative pressure wound therapy, pressure relief devices (PRD), wound debridement devices, hyperbaric oxygen chambers, and physical therapies.
The growth factors are further divided into platelet-derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), Talactoferrin ALFA, thrombin peptide (TP508), and keratinocyte growth factor (KGF).
The negative pressure wound therapy (NPWT) is further classified into standalone NPWT devices, portable NPWT devices, and disposable NPWT devices. The pressure relief devices (PRD) are further classified into mattress and bed.
The hyperbaric oxygen chambers are further classified into monoplace, multiplace, and topical.
On the basis of wound type, the Belgium and Netherlands advance wound care market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers and others. The Belgium diabetic ulcer is projected to witness the highest growth rate of 5.3% during the forecast period to reach a value of USD 7.6 million by 2024.
The Netherlands diabetic ulcer is projected to witness higher growth rate of 5.3% during the forecast period to reach a value of USD 43.4 million by 2024.
On the basis of end users, the Belgium and Netherlands advance wound care market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and community healthcare.n 2017, the Belgium and Netherlands hospital segment is expected to dominate with the market share of 50.8% and 52.5% respectively and is expected to continue this trend till 2024.
On the basis of distribution channel, the Belgium and Netherlands advance wound care market is segmented into direct tenders and retailers. In 2017, the Belgium and Netherlands direct tenders market is expected to dominate the market with a value of USD 21.3 million and 126.7 million respectively.
Some of the major factors driving the market for rising scope of advance wound care market, rising aging and geriatric population, technological advancement, government support, rising incidences of chronic wound, increase in number of surgeries and increasing trend. These factors increase the demand for wound care devices.
- Low awareness, slow growth rate and shrinking market, complex regulatory approval process, competition with other moist dressings are the factors which may hinder the growth of this market.
- Scope for unmet medical needs as well as emerging advance wound care devices will drive the market in future.
Some of the major players operating in this market
The Belgium and Netherlands advance wound care market report contains an in-depth profiling of the key market players, along with the recent developments (new product developments, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market.
- Advance wound care biologics market is growing with the highest CAGR.
- Surgical wounds are driving the market with the highest market share. However, diabetic ulcers are growing with the highest CAGR.
- Hospitals are dominating the end-user segment of Belgium and Netherlands advance wound care market.
Browse Full Report at databridgemarketresearch.com/repor…und-care-market/
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: